CT imaging study of bile duct diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050936

Enrollment

Unknown

Registered

2021-09-08

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The bile duct diseases

Interventions

case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: From September 2021 to September 2026, patients who need to come to our department for enhanced abdominal CT scan due to obstructive jaundice, past medical history or other examinations confirmed bile duct lesions.

Exclusion criteria

Exclusion criteria: 1. Patients who have been or are suspected of being pregnant or breastfeeding. 2. Patients with known hypersensitivity or hypersensitivity reactions to iodine-containing contrast agents, or hypersensitivity to allergens (including drugs). 3. Currently suffering from hyperthyroidism. 4. Patients with severe renal insufficiency (serum creatinine value >= 177umol/L). 5. Suffering from severe organ failure. 6. Have concomitant diseases that are unlikely to complete the procedures required for this trial.

Design outcomes

Primary

Measure	Time frame
CT value;Size of lesion;Overall survival;Progression-free survival;	—

Countries

China

Contacts

Public ContactLyu Peijie

The First Affiliated Hospital of Zhengzhou University

lvpeijie2@163.com+86 15038203469

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026